Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.
Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.
Pain Med. 2018 Feb 1;19(2):297-306. doi: 10.1093/pm/pnw263.
There is little empirical evidence supporting the long-term use of opioid therapy for chronic pain, suggesting the need to reevaluate the role of opioids in chronic pain management. Few studies have considered opioid use and opioid cessation from the perspective of the patient.
This prospective structured interview study included 150 new patients seeking treatment for chronic pain at an outpatient tertiary care pain clinic.
Of the 150 patients, 56% (N = 84) reported current opioid use. Opioids users reported higher pain severity (t(137) = -3.75, P < 0.001), worse physical functioning (t(136) = -3.82, P < 0.001), and more symptoms of depression (t(136) = -1.98, P = 0.050) than nonusers. Among opioid users, 45.6% reported high pain (>7), 60.8% reported low functioning (>7), and 71.4% reported less than a 30% reduction in pain severity since starting opioids, suggesting that many patients are unlikely to be receiving adequate benefit. Overall, 66.3% of current opioid users reported moderate to high opioid-related difficulties on the prescribed opioids difficulties scale, and patients with depression were more likely to report greater difficulties. There was no association between helpfulness of opioids over the past month and opioid-related difficulties (r(75) = -0.07, P = 0.559), current pain severity (r(72)=0.05, P = 0.705), or current pain interference (r(72) = 0.20, P = 0.095).
Despite clinical indicators that question the benefit, patients may continue to report that their opioids are helpful. Such discrepancies in patients' perceptions will likely pose significant barriers for implementing opioid cessation guidelines in clinical practice.
长期使用阿片类药物治疗慢性疼痛的证据有限,这表明需要重新评估阿片类药物在慢性疼痛管理中的作用。很少有研究从患者的角度考虑阿片类药物的使用和停药。
本前瞻性结构访谈研究纳入了 150 名在门诊三级护理疼痛诊所寻求慢性疼痛治疗的新患者。
在 150 名患者中,56%(N=84)报告目前正在使用阿片类药物。阿片类药物使用者报告的疼痛严重程度更高(t(137)=-3.75,P<0.001),身体功能更差(t(136)=-3.82,P<0.001),抑郁症状更多(t(136)=-1.98,P=0.050)。在阿片类药物使用者中,45.6%报告疼痛高度(>7),60.8%报告功能低度(>7),71.4%报告自开始使用阿片类药物以来疼痛严重程度减轻不到 30%,这表明许多患者可能没有得到足够的益处。总体而言,目前正在使用阿片类药物的患者中有 66.3%报告在服用处方阿片类药物时存在中度至高度相关困难,而有抑郁症状的患者更有可能报告存在更大的困难。过去一个月阿片类药物的帮助程度与阿片类药物相关困难(r(75)=-0.07,P=0.559)、当前疼痛严重程度(r(72)=0.05,P=0.705)或当前疼痛干扰(r(72)=0.20,P=0.095)之间没有关联。
尽管有临床指标表明阿片类药物的益处存在疑问,但患者可能仍会报告他们的阿片类药物是有帮助的。患者感知上的这种差异可能会给在临床实践中实施阿片类药物停药指南带来重大障碍。